{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T12:48:47Z","timestamp":1767876527484,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020230","name":"Jilin Province Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jpba.2023.115555","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T21:14:45Z","timestamp":1688591685000},"page":"115555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effects of (20\u00a0R)-Panaxadiol on NAFLD using non\u2011targeted metabolomics in stool"],"prefix":"10.1016","volume":"234","author":[{"given":"Jianshu","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanghui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqian","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengying","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2023.115555_bib1","first-page":"283","article-title":"Nonalcoholic fatty liver disease","volume":"8","author":"Schaffner","year":"1986","journal-title":"Prog. Liver Dis."},{"issue":"4","key":"10.1016\/j.jpba.2023.115555_bib2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11901-017-0378-2","article-title":"Natural history of NAFLD\/NASH","volume":"16","author":"Ekstedt","year":"2017","journal-title":"Curr. Hepatol. Rep."},{"key":"10.1016\/j.jpba.2023.115555_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121185","article-title":"Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics","volume":"312","author":"Khairnar","year":"2023","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.jpba.2023.115555_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052350","article-title":"Treatments for NAFLD: state of art","volume":"22","author":"Mantovani","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.jpba.2023.115555_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","article-title":"Gut microbial metabolites in obesity, NAFLD and T2DM","volume":"15","author":"Canfora","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.jpba.2023.115555_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jpba.2023.115555_bib7","doi-asserted-by":"crossref","first-page":"32002","DOI":"10.1038\/srep32002","article-title":"Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.jpba.2023.115555_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat. Med"},{"key":"10.1016\/j.jpba.2023.115555_bib9","doi-asserted-by":"crossref","unstructured":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH %J Hepatology [J]. 2013, 57(2).","DOI":"10.1002\/hep.26093"},{"issue":"2","key":"10.1016\/j.jpba.2023.115555_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.28572","article-title":"Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach","volume":"65","author":"Chierico","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jpba.2023.115555_bib11","first-page":"15","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jpba.2023.115555_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2019.108256","article-title":"Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice","volume":"75","author":"Liu","year":"2020","journal-title":"J. Nutr. Biochem"},{"key":"10.1016\/j.jpba.2023.115555_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.622841","article-title":"Ginsenosides improve nonalcoholic fatty liver disease via integrated regulation of gut microbiota, inflammation and energy homeostasis","volume":"12","author":"Liang","year":"2021","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.jpba.2023.115555_bib14","doi-asserted-by":"crossref","unstructured":"Guan F.J. M. (20R)-Panaxadiol as a Natural Active Component with Anti-Obesity Effects on ob\/ob Mice via Modulating the Gut Microbiota [J]. 2022, 27.","DOI":"10.3390\/molecules27082502"},{"issue":"1","key":"10.1016\/j.jpba.2023.115555_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.jpba.2023.115555_bib16","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Le Roy","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jpba.2023.115555_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.841132","article-title":"Rifaximin ameliorates non-alcoholic steatohepatitis in mice through regulating gut microbiome-related bile acids","volume":"13","author":"Jian","year":"2022","journal-title":"Front Pharmacol."},{"issue":"7","key":"10.1016\/j.jpba.2023.115555_bib18","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","article-title":"Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product","volume":"162","author":"Hoshino","year":"1999","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jpba.2023.115555_bib19","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.jpba.2023.115555_bib20","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1172\/JCI97953","article-title":"Role of prostanoids in gastrointestinal cancer","volume":"128","author":"Wang","year":"2018","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.jpba.2023.115555_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00018-022-04319-w","article-title":"Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2\/EP4 pathway","volume":"79","author":"Cao","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.jpba.2023.115555_bib22","article-title":"Definition of prostaglandin E2-EP2 signals in the colon tumor microenvironment that amplify inflammation and tumor","author":"Xiaojun","year":"2015","journal-title":"Growth"},{"issue":"7","key":"10.1016\/j.jpba.2023.115555_bib23","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.jpba.2023.115555_bib24","first-page":"3648","article-title":"Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease","volume":"8","author":"Mao","year":"2015","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jpba.2023.115555_bib25","unstructured":"Schlattjan M., Messer K., Mcgeough M., et al. NLRP3 inflammasome activation is required for fibrosis development in NAFLD [J]. 2014."},{"issue":"6","key":"10.1016\/j.jpba.2023.115555_bib26","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jpba.2023.115555_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2337\/db08-0473","article-title":"Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistance","volume":"58","author":"Padmalayam","year":"2009","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.jpba.2023.115555_bib28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/pro.5560070125","article-title":"From lipoic acid to multi-enzyme complexes","volume":"7","author":"Reed","year":"1998","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.jpba.2023.115555_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF03165968","article-title":"Lipoic acid prevents body weight gain induced by a high fat diet in rats: effects on intestinal sugar transport","volume":"65","author":"Prieto-Hontoria","year":"2009","journal-title":"J. Physiol. Biochem"},{"issue":"14","key":"10.1016\/j.jpba.2023.115555_bib30","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.2174\/1381612811319140014","article-title":"Biosynthesis of flavin cofactors in man: implications in health and disease","volume":"19","author":"Barile","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.jpba.2023.115555_bib31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/HJH.0000000000001529","article-title":"MiR-195 modulates oxidative stress-induced apoptosis and mitochondrial energy production in human trophoblasts via flavin adenine dinucleotide-dependent oxidoreductase domain-containing protein 1 and pyruvate dehydrogenase phosphatase regulatory subunit","volume":"36","author":"Wang","year":"2018","journal-title":"J. Hypertens."},{"issue":"6","key":"10.1016\/j.jpba.2023.115555_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/hep4.1691","article-title":"Flavin adenine dinucleotide depletion caused by electron transfer flavoprotein subunit alpha haploinsufficiency leads to hepatic steatosis and injury in zebrafish","volume":"5","author":"Park","year":"2021","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jpba.2023.115555_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.788558","article-title":"Ursodeoxycholic acid treatment restores gut microbiota and alleviates liver inflammation in non-alcoholic steatohepatitic mouse model","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharm."},{"issue":"47","key":"10.1016\/j.jpba.2023.115555_bib34","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jafc.1c05596","article-title":"Novel sesquiterpene glycoside from loquat leaf alleviates type 2 diabetes mellitus combined with nonalcoholic fatty liver disease by improving insulin resistance, oxidative stress, inflammation, and gut microbiota composition","volume":"69","author":"Chen","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"12","key":"10.1016\/j.jpba.2023.115555_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.634","article-title":"Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease","volume":"11","author":"Yu","year":"2021","journal-title":"Clin. Transl. Med"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:35:22Z","timestamp":1760002522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523003242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":35,"alternative-id":["S0731708523003242"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115555","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of (20\u00a0R)-Panaxadiol on NAFLD using non\u2011targeted metabolomics in stool","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115555"}}